Amended recombinant cells for the production and delivery of gamma interferon as an antiviral agent, adjuvant and vaccine accelerant
US7338794B2 · kind B2 · utility
9Cited by
5References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 7, 2003 |
| Grant date | Mar 4, 2008 |
| Priority date | — |
| Expiry date | Mar 24, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/55522
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides active cytokine and/or chemokine compositions, as well as inexpensive means for the production, amended-cell encasement of active cytokine and/or chemokine compositions, processing, and delivery of active cytokine and/or chemokine compositions. The subject invention also provides methods of treatment and methods of accelerating an immune response comprising the administration of amended recombinant cell (ARC) containing cytokine and/or chemokine compositions to animals or humans.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.